Host-defense mechanism of the ocular surfaces

Bioscience Reports

Volumn 21, Issue 4, 2001, Pages 463-480

  Sack, Robert A ^a   Nunes, Irene ^b   Beaton, Ann ^a   Morris, Carol ^c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CIBA VISION Corporation   (Georgia)

Author keywords

Cornea; Defence mechanism; Ocular surface

Indexed keywords

ASSAULT; CORNEA; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; ENVIRONMENT; HOST RESISTANCE; HUMAN; KERATITIS; MICROBIAL IMMUNITY; RISK FACTOR; SHORT SURVEY; SURFACE PROPERTY; WOUND HEALING;

ANTI-INFECTIVE AGENTS; CORNEA; EPITHELIUM; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MUCOUS MEMBRANE; NEUTROPHILS; PROTEINS; TEARS;

EID: 0035724878     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017943826684     Document Type: Short Survey

References (126)

1. Resistance to infection of the external eye: The role of tears
2. The defense mechanism of the outer eye
3. The defences of the ocular surface
4. Eyelid secretions and the prevention and production of disease
5. Antibacterial protection of the ocular surface
6. Tear lipocalin and the eye's front line of defence
7. The meibomian glands and tear film lipids. Structure function, and control
8. Meibomian gland lipids, evaporation, and tear film stability
9. Tear dynamics and dry eye
10. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality
11. Meibomian secretions in chronic blepharitis
12. Association of meibum oleic acid with meibomian seborrhea
13. The dynamics and drainage of tears
14. Turnover and drainage of tears
15. Standardization of tear protein determinations: The effects of sampling, flow rate and vascular permeability
16. Origin and biosynthesis of human tear fluid proteins
17. Changes in human tear protein levels with progressively increasing stimulus
18. Signal transduction and control of lacrimal gland protein secretion: A review
19. Diurnal tear cycle: Evidence for a nocturnal inflammatory constitutive tear fluid
20. Human tears: Glucose instabilities
21. Comlement and complement regulatory proteins in human tears
22. Structure and biological actions of lactoferrin
23. Lactoferrin: A multifunctional glycoprotein
24. The role of lactoferrin in the nonspecific immune response on the ocular surface
25. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes
26. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils
27. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions
28. Killing of gram-negative bacteria by lactoferrin and lysozyme
29. Synergic antistaphylococcal properties of lactoferrin and lysozyme
30. Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens
31. Lactoferrin. Antiviral activity of lactoferrin
32. Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery
33. Regulation of epidermal Langerhans cell migration by lactoferrin
34. Interaction of tear lipocalin with lysozyme and lactoferrin
35. Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin
36. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus I activity in vitro
37. Inhibitors of complement activity in human breast-milk: A proposed hypothesis of their physiological significance
38. The salivary lipocalin von Ebner's gland protein is a cysteine proteinase inhibitor
39. Does tear specific lipocalin function as a cysteine protease inhibitor during the normal diurnal cycle?
40. A conserved disulfide motif in human tear lipocalins influences ligand binding
41. Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium
42. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis
43. Tear lipocalins: Potential lipid scavengers for the corneal surface
44. Lipocalin as a component of human tear surface active substances
45. The role of tear proteins in tear film stability in the dry eye patient and in the rabbit
46. Components responsible for the surface tension of human tears
47. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid
48. Inhibition of neutrophil elastase by mucus glycoprotein
49. Tissue distribution of antileukoprotease and lysozyme in humans
50. Localization of a secretory leukocyte protease inhibitor in the human ocular surface
51. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens
52. Antimicrobial defensin peptides of human ocular surface
53. Antimicrobial defensin peptides of the human ocular surface
54. Ocular surface epithelia express mRNA for human beta defensin 2
55. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense
56. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
57. Microbial peptides as potential new antifungals
58. z is the principal bactericide for staphylococci and other gram-positive bacteria in human tears
59. Degradation of outer membrane protein A in escherichia coli killing by neutrophil elastase
60. Secretory component in human amniotic fluid and gestational tissues: A potential endogenous phospholipase A2 inhibitor
61. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: Homeostatic mechanisms
62. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca
63. Vitronectin-possible contribution to the closed-eye external host-defense mechanism
64. NGAL and MMP-9 in tear fluid
65. Structure and composition of rat precorneal tear film. A study by an in vivo cryofixation
66. Sialomucin complex at the rat ocular surface: A new model for ocular surface protection
67. Cellular origin of mucins of the ocular surface tear film
68. Stimulation of goblet cell mucous secretion by activation of nerves in rat conjunctiva
69. Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells
70. MUC5AC mucin is a component of the human precorneal tear film
71. Secreted human conjunctival mucus contains MUC5AC glycoforms
72. Polydispersity of normal human conjunctival mucins
73. Characterization of ocular mucus extracts by crossed immunoelectrophoretic techniques
74. sIgA, glycoproteins and soluble mucin in reflex and closed eye tears. Does the epithelium shed its membrane-bound mucin?
75. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone
76. Homeostatic mechanisms that operate in the tear film during eye closure-identification of tear borne complement regulators
77. Dual function of human IgA antibodies: Inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells
78. In vitro effects of IgA on human polymorphonuclear leukocytes
79. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils
80. Immunoglobulin A antibodies against Pseudomonas aeruginosa in the tear fluid of contact lens wearers
81. Role of mucosal IgA in the resistance to Acanthamoeba keratitis
82. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis
83. Role of mucosal IgA in the resistance to Acanthamoeba keratitis
84. Monoclonal IgA antibodies protect against Acanthamoeba keratitis
85. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice
86. Polymorphonuclear leukocyte cells and elastase in tears
87. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands
88. Contribution of the epithelium to the stability of the tear film
89. Diurnal variations in tear glycoproteins: Evidence for an epithelial origin for the major non-reducible > or = 450 kDa sialoglycoprotein(s)
90. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba
91. Acanthamoebae bind to rabbit corneal epithelium in vitro
92. Cell adhesion molecules in the pathogenesis of and host defence against microbial infection
93. Molecular basis of mucin-Pseudomonas interactions
94. Characterization of Pseudomonas aeruginosa adherence to mouse corneas in organ culture
95. The effects of fibronectin on the adherence of bacteria to corneal epithelium
96. Mucin-bacterial binding assays. Mucin methods and protocols
97. Human tear film components bind Pseudomonas aeruginosa
98. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity
99. Plasminogen activator inhibitor type 2 in human corneal epithelium
100. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland
101. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacriminal gland
102. Alpha2-macroglobulin is present in and synthesized by the cornea
103. Local control of alpha1-proteinase inhibitor levels: Regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines
104. Ascorbic acid content of human corneal epithelium
105. Ocular oxidants and antioxidant protection
106. The immunology of the eye and its systemic interactions
107. The immunology of corneal graft rejection
108. Immune privilege and immune regulation in the eye
109. The role of cytokines in the pathogenesis of inflammatory eye disease
110. Corneal thickness changes following sleep and overnight contact lens wear in the primate (Macaca fascicularis)
111. Effects of hypoxia on corneal epithelial permeability
112. A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae
113. Temporal sequence of changes in tear film composition during sleep
114. The effect of eye closure on protein and complement deposition on group IV hydrogel contact lenses: Relationship to tear flow dynamics
115. Towards a closed eye model of the pre-ocular tear layer
116. Tear proteases as a function of eye closure
117. Diurnal variations in angiostatin in human tear fluid: A possible role in prevention of corneal neovascularization
118. Examination of the conjunctival microbiota after 8 hr of eye closure
119. Antioxidant enzymes in human bears
120. Tear fluid content of electrochemically active components including water soluble antioxidants
121. Inhibition of hydroxyl radical formation by human tears
122. 2-macroglobulin and binding is inhibited by heparin
123. Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas
124. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis